The relevance of EMT in breast cancer metastasis: Correlation or causality?

FEBS Letters

Volumn 589, Issue 14, 2015, Pages 1577-1587

  Bill, Ruben ^a   Christofori, Gerhard ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Breast cancer; Cell migration; Epithelial to mesenchymal transition; Metastasis; Mouse model

Indexed keywords

BIOLOGICAL MARKER; ONCOPROTEIN;

BREAST METASTASIS; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CIRCULATING TUMOR CELL; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRAVASATION; GENE EXPRESSION PROFILING; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; ANIMAL; BREAST TUMOR; DISEASE MODEL; FEMALE; METASTASIS; MOUSE; PATHOLOGY; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS;

EID: 84930179858     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.05.002     Document Type: Review

References (133)

1. M.A. Nieto Epithelial plasticity: a common theme in embryonic and cancer cells Science 342 2013 1234850
2. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
3. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J. Clin. Investig. 119 2009 1420 1428
4. V.G. Cooke, V.S. LeBleu, D. Keskin, Z. Khan, J.T. O'Connell, Y. Teng, M.B. Duncan, L. Xie, G. Maeda, S. Vong, H. Sugimoto, R.M. Rocha, A. Damascena, R.R. Brentani, and R. Kalluri Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway Cancer Cell 21 2012 66 81
5. N. Tiwari, V.K. Tiwari, L. Waldmeier, P.J. Balwierz, P. Arnold, M. Pachkov, N. Meyer-Schaller, D. Schubeler, E. van Nimwegen, and G. Christofori Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming Cancer Cell 23 2013 768 783
6. H. Zheng, M. Shen, Y.L. Zha, W. Li, Y. Wei, M.A. Blanco, G. Ren, T. Zhou, P. Storz, H.Y. Wang, and Y. Kang PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis Cancer Cell 26 2014 358 373
7. M. Labelle, S. Begum, and R.O. Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 2011 576 590
8. W.L. Tam, and R.A. Weinberg The epigenetics of epithelial-mesenchymal plasticity in cancer Nat. Med. 19 2013 1438 1449
9. C. Scheel, and R.A. Weinberg Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links Semin. Cancer Biol. 22 2012 396 403
10. J.J. Christiansen, and A.K. Rajasekaran Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis Cancer Res. 66 2006 8319 8326
11. T. Brabletz To differentiate or not - routes towards metastasis Nat. Rev. Cancer 12 2012 425 436
12. S. Brabletz, and T. Brabletz The ZEB/miR-200 feedback loop - a motor of cellular plasticity in development and cancer? EMBO Rep. 11 2010 670 677
13. J.H. Yuan, F. Yang, F. Wang, J.Z. Ma, Y.J. Guo, Q.F. Tao, F. Liu, W. Pan, T.T. Wang, C.C. Zhou, S.B. Wang, Y.Z. Wang, Y. Yang, N. Yang, W.P. Zhou, G.S. Yang, and S.H. Sun A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma Cancer Cell 25 2014 666 681
14. A. Fantozzi, and G. Christofori Mouse models of breast cancer metastasis Breast Cancer Res. 8 2006 212
15. J.I. Herschkowitz, K. Simin, V.J. Weigman, I. Mikaelian, J. Usary, Z. Hu, K.E. Rasmussen, L.P. Jones, S. Assefnia, S. Chandrasekharan, M.G. Backlund, Y. Yin, A.I. Khramtsov, R. Bastein, J. Quackenbush, R.I. Glazer, P.H. Brown, J.E. Green, L. Kopelovich, P.A. Furth, J.P. Palazzo, O.I. Olopade, P.S. Bernard, G.A. Churchill, T. Van Dyke, and C.M. Perou Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biol. 8 2007 R76
16. N. Tiwari, A. Gheldof, M. Tatari, and G. Christofori EMT as the ultimate survival mechanism of cancer cells Semin. Cancer Biol. 22 2012 194 207
17. L. Waldmeier, N. Meyer-Schaller, M. Diepenbruck, and G. Christofori Py2T murine breast cancer cells, a versatile model of TGFbeta-induced EMT in vitro and in vivo PLoS One 7 2012 e48651
18. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R.A. Weinberg Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927 939
19. B.M. Baker, and C.S. Chen Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues J. Cell Sci. 125 2012 3015 3024
20. A.D. Doyle, R.J. Petrie, M.L. Kutys, and K.M. Yamada Dimensions in cell migration Curr. Opin. Cell Biol. 25 2013 642 649
21. P. Friedl, and K. Wolf Tumour-cell invasion and migration: diversity and escape mechanisms Nat. Rev. Cancer 3 2003 362 374
22. D. Tarin, E.W. Thompson, and D.F. Newgreen The fallacy of epithelial mesenchymal transition in neoplasia Cancer Res. 65 2005 5996 6000 discussion 6000-5991
23. A. Haeger, M. Krause, K. Wolf, and P. Friedl Cell jamming: collective invasion of mesenchymal tumor cells imposed by tissue confinement Biochim. Biophys. Acta 1840 2014 2386 2395
24. F. Ahmed, J. Wyckoff, E.Y. Lin, W. Wang, Y. Wang, L. Hennighausen, J. Miyazaki, J. Jones, J.W. Pollard, J.S. Condeelis, and J.E. Segall GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice Cancer Res. 62 2002 7166 7169
25. S.I. Ellenbroek, and J. van Rheenen Imaging hallmarks of cancer in living mice Nat. Rev. Cancer 14 2014 406 418
26. P. Friedl, J. Locker, E. Sahai, and J.E. Segall Classifying collective cancer cell invasion Nat. Cell Biol. 14 2012 777 783
27. M. Yilmaz, and G. Christofori Mechanisms of motility in metastasizing cells Mol. Cancer Res. 8 2010 629 642
28. Y.J. Liu, M. Le Berre, F. Lautenschlaeger, P. Maiuri, A. Callan-Jones, M. Heuze, T. Takaki, R. Voituriez, and M. Piel Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells Cell 160 2015 659 672
29. K. Pankova, D. Rosel, M. Novotny, and J. Brabek The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells Cell. Mol. Life Sci. 67 2010 63 71
30. M. Parri, and P. Chiarugi Rac and Rho GTPases in cancer cell motility control Cell Commun. Signal. 8 2010 23
31. M. Bergert, S.D. Chandradoss, R.A. Desai, and E. Paluch Cell mechanics control rapid transitions between blebs and lamellipodia during migration Proc. Natl. Acad. Sci. U.S.A. 109 2012 14434 14439
32. T. Lammermann, B.L. Bader, S.J. Monkley, T. Worbs, R. Wedlich-Soldner, K. Hirsch, M. Keller, R. Forster, D.R. Critchley, R. Fassler, and M. Sixt Rapid leukocyte migration by integrin-independent flowing and squeezing Nature 453 2008 51 55
33. M.H. Zaman, L.M. Trapani, A.L. Sieminski, D. Mackellar, H. Gong, R.D. Kamm, A. Wells, D.A. Lauffenburger, and P. Matsudaira Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis Proc. Natl. Acad. Sci. U.S.A. 103 2006 10889 10894
34. K. Maaser, K. Wolf, C.E. Klein, B. Niggemann, K.S. Zanker, E.B. Brocker, and P. Friedl Functional hierarchy of simultaneously expressed adhesion receptors: integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices Mol. Biol. Cell 10 1999 3067 3079
35. S. Berton, B. Belletti, K. Wolf, V. Canzonieri, F. Lovat, A. Vecchione, A. Colombatti, P. Friedl, and G. Baldassarre The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition Mol. Cell. Biol. 29 2009 5031 5045
36. G. Gadea, M. de Toledo, C. Anguille, and P. Roux Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices J. Cell Biol. 178 2007 23 30
37. M. Parri, M.L. Taddei, F. Bianchini, L. Calorini, and P. Chiarugi EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style Cancer Res. 69 2009 2072 2081
38. E. Sahai, and C.J. Marshall Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis Nat. Cell Biol. 5 2003 711 719
39. M.L. Taddei, E. Giannoni, A. Morandi, L. Ippolito, M. Ramazzotti, M. Callari, P. Gandellini, and P. Chiarugi Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells Cell Commun. Signal. 12 2014 24
40. K. Wolf, I. Mazo, H. Leung, K. Engelke, U.H. von Andrian, E.I. Deryugina, A.Y. Strongin, E.B. Brocker, and P. Friedl Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis J. Cell Biol. 160 2003 267 277
41. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387 2392
42. T.T. Lah, M.B. Duran Alonso, and C.J. Van Noorden Antiprotease therapy in cancer: hot or not? Expert Opin. Biol. Ther. 6 2006 257 279
43. R. Stupp, M.E. Hegi, T. Gorlia, S.C. Erridge, J. Perry, Y.K. Hong, K.D. Aldape, B. Lhermitte, T. Pietsch, D. Grujicic, J.P. Steinbach, W. Wick, R. Tarnawski, D.H. Nam, P. Hau, A. Weyerbrock, M.J. Taphoorn, C.C. Shen, N. Rao, L. Thurzo, U. Herrlinger, T. Gupta, R.D. Kortmann, K. Adamska, C. McBain, A.A. Brandes, J.C. Tonn, O. Schnell, T. Wiegel, C.Y. Kim, L.B. Nabors, D.A. Reardon, M.J. van den Bent, C. Hicking, A. Markivskyy, M. Picard, and M. Weller Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Lancet Oncol. 15 2014 1100 1108
44. G.M. Slattum, and J. Rosenblatt Tumour cell invasion: an emerging role for basal epithelial cell extrusion Nat. Rev. Cancer 14 2014 495 501
45. J.S. Liu, J.T. Farlow, A.K. Paulson, M.A. Labarge, and Z.J. Gartner Programmed cell-to-cell variability in Ras activity triggers emergent behaviors during mammary epithelial morphogenesis Cell Rep. 2 2012 1461 1470
46. T.W. Marshall, I.E. Lloyd, J.M. Delalande, I. Nathke, and J. Rosenblatt The tumor suppressor adenomatous polyposis coli controls the direction in which a cell extrudes from an epithelium Mol. Biol. Cell 22 2011 3962 3970
47. J.B. Wyckoff, S.E. Pinner, S. Gschmeissner, J.S. Condeelis, and E. Sahai ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo Curr. Biol. 16 2006 1515 1523
48. P. Friedl, and K. Wolf Plasticity of cell migration: a multiscale tuning model J. Cell Biol. 188 2010 11 19
49. K.J. Cheung, E. Gabrielson, Z. Werb, and A.J. Ewald Collective invasion in breast cancer requires a conserved basal epithelial program Cell 155 2013 1639 1651
50. Y. Hegerfeldt, M. Tusch, E.B. Brocker, and P. Friedl Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies Cancer Res. 62 2002 2125 2130
51. W. Shih, and S. Yamada N-cadherin-mediated cell-cell adhesion promotes cell migration in a three-dimensional matrix J. Cell Sci. 125 2012 3661 3670
52. E. Theveneau, and R. Mayor Cadherins in collective cell migration of mesenchymal cells Curr. Opin. Cell Biol. 24 2012 677 684
53. U. Cavallaro, and G. Christofori Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat. Rev. Cancer 4 2004 118 132
54. I.J. Fidler The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis Eur. J. Cancer 9 1973 223 227
55. I.R. Hart New evidence for tumour embolism as a mode of metastasis J. Pathol. 219 2009 275 276
56. B. Kusters, G. Kats, I. Roodink, K. Verrijp, P. Wesseling, D.J. Ruiter, R.M. de Waal, and W.P. Leenders Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis Oncogene 26 2007 5808 5815
57. L.A. Liotta, M.G. Saidel, and J. Kleinerman The significance of hematogenous tumor cell clumps in the metastatic process Cancer Res. 36 1976 889 894
58. T. Sugino, T. Yamaguchi, G. Ogura, A. Saito, T. Hashimoto, N. Hoshi, S. Yoshida, S. Goodison, and T. Suzuki Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers BMC Med. 2 2004 9
59. T. Brabletz, A. Jung, S. Reu, M. Porzner, F. Hlubek, L.A. Kunz-Schughart, R. Knuechel, and T. Kirchner Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment Proc. Natl. Acad. Sci. U.S.A. 98 2001 10356 10361
60. Y. Husemann, J.B. Geigl, F. Schubert, P. Musiani, M. Meyer, E. Burghart, G. Forni, R. Eils, T. Fehm, G. Riethmuller, and C.A. Klein Systemic spread is an early step in breast cancer Cancer Cell 13 2008 58 68
61. E. Beerling, L. Ritsma, N. Vrisekoop, P.W. Derksen, and J. van Rheenen Intravital microscopy: new insights into metastasis of tumors J. Cell Sci. 124 2011 299 310
62. A. Fantozzi, D.C. Gruber, L. Pisarsky, C. Heck, A. Kunita, M. Yilmaz, N. Meyer-Schaller, K. Cornille, U. Hopfer, M. Bentires-Alj, and G. Christofori VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation Cancer Res. 74 2014 1566 1575
63. H.L. Goel, and A.M. Mercurio VEGF targets the tumour cell Nat. Rev. Cancer 13 2013 871 882
64. M. Gerlinger, A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, S. Begum, N.Q. McDonald, A. Butler, D. Jones, K. Raine, C. Latimer, C.R. Santos, M. Nohadani, A.C. Eklund, B. Spencer-Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P.A. Futreal, and C. Swanton Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N. Engl. J. Med. 366 2012 883 892
65. A.P. Patel, I. Tirosh, J.J. Trombetta, A.K. Shalek, S.M. Gillespie, H. Wakimoto, D.P. Cahill, B.V. Nahed, W.T. Curry, R.L. Martuza, D.N. Louis, O. Rozenblatt-Rosen, M.L. Suva, A. Regev, and B.E. Bernstein Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma Science 344 2014 1396 1401
66. S. Pavlides, D. Whitaker-Menezes, R. Castello-Cros, N. Flomenberg, A.K. Witkiewicz, P.G. Frank, M.C. Casimiro, C. Wang, P. Fortina, S. Addya, R.G. Pestell, U.E. Martinez-Outschoorn, F. Sotgia, and M.P. Lisanti The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma Cell Cycle 8 2009 3984 4001
67. R.J. Paccione, H. Miyazaki, V. Patel, A. Waseem, J.S. Gutkind, Z.E. Zehner, and W.A. Yeudall Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility Mol. Cancer Ther. 7 2008 2894 2903
68. H. Ledford Cancer theory faces doubts Nature 472 2011 273
69. G. Francia, W. Cruz-Munoz, S. Man, P. Xu, and R.S. Kerbel Mouse models of advanced spontaneous metastasis for experimental therapeutics Nat. Rev. Cancer 11 2011 135 141
70. A. Prat, J.S. Parker, O. Karginova, C. Fan, C. Livasy, J.I. Herschkowitz, X. He, and C.M. Perou Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Res. 12 2010 R68
71. A.J. Trimboli, K. Fukino, A. de Bruin, G. Wei, L. Shen, S.M. Tanner, N. Creasap, T.J. Rosol, M.L. Robinson, C. Eng, M.C. Ostrowski, and G. Leone Direct evidence for epithelial-mesenchymal transitions in breast cancer Cancer Res. 68 2008 937 945
72. E. Forrester, A. Chytil, B. Bierie, M. Aakre, A.E. Gorska, A.R. Sharif-Afshar, W.J. Muller, and H.L. Moses Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis Cancer Res. 65 2005 2296 2302
73. S. Giampieri, C. Manning, S. Hooper, L. Jones, C.S. Hill, and E. Sahai Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility Nat. Cell Biol. 11 2009 1287 1296
74. P.W. Derksen, T.M. Braumuller, E. van der Burg, M. Hornsveld, E. Mesman, J. Wesseling, P. Krimpenfort, and J. Jonkers Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice Dis. Models Mech. 4 2011 347 358
75. P.W. Derksen, X. Liu, F. Saridin, H. van der Gulden, J. Zevenhoven, B. Evers, J.R. van Beijnum, A.W. Griffioen, J. Vink, P. Krimpenfort, J.L. Peterse, R.D. Cardiff, A. Berns, and J. Jonkers Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis Cancer Cell 10 2006 437 449
76. L. Strizzi, C. Bianco, N. Normanno, M. Seno, C. Wechselberger, B. Wallace-Jones, N.I. Khan, M. Hirota, Y. Sun, M. Sanicola, and D.S. Salomon Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice J. Cell. Physiol. 201 2004 266 276
77. E.L. McCoy, R. Iwanaga, P. Jedlicka, N.S. Abbey, L.A. Chodosh, K.A. Heichman, A.L. Welm, and H.L. Ford Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition J. Clin. Investig. 119 2009 2663 2677
78. A.D. Rhim, E.T. Mirek, N.M. Aiello, A. Maitra, J.M. Bailey, F. McAllister, M. Reichert, G.L. Beatty, A.K. Rustgi, R.H. Vonderheide, S.D. Leach, and B.Z. Stanger EMT and dissemination precede pancreatic tumor formation Cell 148 2012 349 361
79. J. Massague TGFbeta signalling in context Nat. Rev. Mol. Cell Biol. 13 2012 616 630
80. R.S. Muraoka, Y. Koh, L.R. Roebuck, M.E. Sanders, D. Brantley-Sieders, A.E. Gorska, H.L. Moses, and C.L. Arteaga Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1 Mol. Cell. Biol. 23 2003 8691 8703
81. R.S. Muraoka-Cook, H. Kurokawa, Y. Koh, J.T. Forbes, L.R. Roebuck, M.H. Barcellos-Hoff, S.E. Moody, L.A. Chodosh, and C.L. Arteaga Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors Cancer Res. 64 2004 9002 9011
82. R.S. Muraoka-Cook, I. Shin, J.Y. Yi, E. Easterly, M.H. Barcellos-Hoff, J.M. Yingling, R. Zent, and C.L. Arteaga Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression Oncogene 25 2006 3408 3423
83. P.M. Siegel, W. Shu, R.D. Cardiff, W.J. Muller, and J. Massague Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis Proc. Natl. Acad. Sci. U.S.A. 100 2003 8430 8435
84. M.Y. Kim, T. Oskarsson, S. Acharyya, D.X. Nguyen, X.H. Zhang, L. Norton, and J. Massague Tumor self-seeding by circulating cancer cells Cell 139 2009 1315 1326
85. S.V. Novitskiy, E. Forrester, M.W. Pickup, A.E. Gorska, A. Chytil, M. Aakre, D. Polosukhina, P. Owens, D.R. Yusupova, Z. Zhao, F. Ye, Y. Shyr, and H.L. Moses Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis Breast Cancer Res. 16 2014 425
86. L. Yang, J. Huang, X. Ren, A.E. Gorska, A. Chytil, M. Aakre, D.P. Carbone, L.M. Matrisian, A. Richmond, P.C. Lin, and H.L. Moses Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis Cancer Cell 13 2008 23 35
87. A.K. Perl, P. Wilgenbus, U. Dahl, H. Semb, and G. Christofori A causal role for E-cadherin in the transition from adenoma to carcinoma Nature 392 1998 190 193
88. F. Lehembre, M. Yilmaz, A. Wicki, T. Schomber, K. Strittmatter, D. Ziegler, A. Kren, P. Went, P.W. Derksen, A. Berns, J. Jonkers, and G. Christofori NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin EMBO J. 27 2008 2603 2615
89. T.T. Onder, P.B. Gupta, S.A. Mani, J. Yang, E.S. Lander, and R.A. Weinberg Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways Cancer Res. 68 2008 3645 3654
90. J.H. Tsai, J.L. Donaher, D.A. Murphy, S. Chau, and J. Yang Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis Cancer Cell 22 2012 725 736
91. S.E. Moody, D. Perez, T.C. Pan, C.J. Sarkisian, C.P. Portocarrero, C.J. Sterner, K.L. Notorfrancesco, R.D. Cardiff, and L.A. Chodosh The transcriptional repressor Snail promotes mammary tumor recurrence Cancer Cell 8 2005 197 209
92. M. Diepenbruck, L. Waldmeier, R. Ivanek, P. Berninger, P. Arnold, E. van Nimwegen, and G. Christofori Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition J. Cell Sci. 127 2014 1523 1536
93. A. Kuzmanov, U. Hopfer, P. Marti, N. Meyer-Schaller, M. Yilmaz, and G. Christofori LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling Mol. Oncol. 8 2014 401 416
94. J. Vaage, and J.P. Harlos Spontaneous metastasis from primary C3H mouse mammary tumors Cancer Res. 47 1987 547 550
95. T. Shibue, and R.A. Weinberg Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment Semin. Cancer Biol. 21 2011 99 106
96. N. Reymond, B.B. d'Agua, and A.J. Ridley Crossing the endothelial barrier during metastasis Nat. Rev. Cancer 13 2013 858 870
97. A.K. Shenoy, and J. Lu Cancer cells remodel themselves and vasculature to overcome the endothelial barrier Cancer Lett. 2014
98. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
99. C. Jean, X.L. Chen, J.O. Nam, I. Tancioni, S. Uryu, C. Lawson, K.K. Ward, C.T. Walsh, N.L. Miller, M. Ghassemian, P. Turowski, E. Dejana, S. Weis, D.A. Cheresh, and D.D. Schlaepfer Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function J. Cell Biol. 204 2014 247 263
100. D. Padua, X.H. Zhang, Q. Wang, C. Nadal, W.L. Gerald, R.R. Gomis, and J. Massague TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4 Cell 133 2008 66 77
101. H. Peinado, S. Lavotshkin, and D. Lyden The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts Semin. Cancer Biol. 21 2011 139 146
102. A. Borrull, S. Ghislin, F. Deshayes, J. Lauriol, C. Alcaide-Loridan, and S. Middendorp Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells J. Cancer Res. Clin. Oncol. 138 2012 1145 1154
103. N. Aceto, A. Bardia, D.T. Miyamoto, M.C. Donaldson, B.S. Wittner, J.A. Spencer, M. Yu, A. Pely, A. Engstrom, H. Zhu, B.W. Brannigan, R. Kapur, S.L. Stott, T. Shioda, S. Ramaswamy, D.T. Ting, C.P. Lin, M. Toner, D.A. Haber, and S. Maheswaran Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis Cell 158 2014 1110 1122
104. C.L. Chaffer, J.P. Brennan, J.L. Slavin, T. Blick, E.W. Thompson, and E.D. Williams Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2 Cancer Res. 66 2006 11271 11278
105. J. Bockhorn, A. Prat, Y.F. Chang, X. Liu, S. Huang, M. Shang, C. Nwachukwu, M.J. Gomez-Vega, J.C. Harrell, O.I. Olopade, C.M. Perou, and H. Liu Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models Cancer Res. 74 2014 7406 7417
106. O.H. Ocana, R. Corcoles, A. Fabra, G. Moreno-Bueno, H. Acloque, S. Vega, A. Barrallo-Gimeno, A. Cano, and M.A. Nieto Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1 Cancer Cell 22 2012 709 724
107. M. Stankic, S. Pavlovic, Y. Chin, E. Brogi, D. Padua, L. Norton, J. Massague, and R. Benezra TGF-beta-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition Cell Rep. 5 2013 1228 1242
108. S. Liu, Y. Cong, D. Wang, Y. Sun, L. Deng, Y. Liu, R. Martin-Trevino, L. Shang, S.P. McDermott, M.D. Landis, S. Hong, A. Adams, R. D'Angelo, C. Ginestier, E. Charafe-Jauffret, S.G. Clouthier, D. Birnbaum, S.T. Wong, M. Zhan, J.C. Chang, and M.S. Wicha Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts Stem Cell Rep. 2 2014 78 91
109. T. Shibue, and R.A. Weinberg Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs Proc. Natl. Acad. Sci. U.S.A. 106 2009 10290 10295
110. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lonning, A.L. Borresen-Dale, P.O. Brown, and D. Botstein Molecular portraits of human breast tumours Nature 406 2000 747 752
111. E. Senkus, S. Kyriakides, F. Penault-Llorca, P. Poortmans, A. Thompson, S. Zackrisson, and F. Cardoso Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann. Oncol. 24 Suppl. 6 2013 vi7 23
112. H.P. Sinn, and H. Kreipe A brief overview of the WHO classification of breast tumors, 4th Edition, focusing on issues and updates from the 3rd Edition Breast Care (Basel) 8 2013 149 154
113. N. Cancer Genome Atlas Comprehensive molecular portraits of human breast tumours Nature 490 2012 61 70
114. B. Weigelt, C. Eberle, C.F. Cowell, C.K. Ng, and J.S. Reis-Filho Metaplastic breast carcinoma: more than a special type Nat. Rev. Cancer 14 2014 147 148
115. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, P.E. Lonning, and A.L. Borresen-Dale Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. U.S.A. 98 2001 10869 10874
116. J.H. Taube, J.I. Herschkowitz, K. Komurov, A.Y. Zhou, S. Gupta, J. Yang, K. Hartwell, T.T. Onder, P.B. Gupta, K.W. Evans, B.G. Hollier, P.T. Ram, E.S. Lander, J.M. Rosen, R.A. Weinberg, and S.A. Mani Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes Proc. Natl. Acad. Sci. U.S.A. 107 2010 15449 15454
117. M. Shipitsin, L.L. Campbell, P. Argani, S. Weremowicz, N. Bloushtain-Qimron, J. Yao, T. Nikolskaya, T. Serebryiskaya, R. Beroukhim, M. Hu, M.K. Halushka, S. Sukumar, L.M. Parker, K.S. Anderson, L.N. Harris, J.E. Garber, A.L. Richardson, S.J. Schnitt, Y. Nikolsky, R.S. Gelman, and K. Polyak Molecular definition of breast tumor heterogeneity Cancer Cell 11 2007 259 273
118. X. Li, M.T. Lewis, J. Huang, C. Gutierrez, C.K. Osborne, M.F. Wu, S.G. Hilsenbeck, A. Pavlick, X. Zhang, G.C. Chamness, H. Wong, J. Rosen, and J.C. Chang Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy J. Natl Cancer Inst. 100 2008 672 679
119. P. Farmer, H. Bonnefoi, P. Anderle, D. Cameron, P. Wirapati, V. Becette, S. Andre, M. Piccart, M. Campone, E. Brain, G. Macgrogan, T. Petit, J. Jassem, F. Bibeau, E. Blot, J. Bogaerts, M. Aguet, J. Bergh, R. Iggo, and M. Delorenzi A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer Nat. Med. 15 2009 68 74
120. C.J. Creighton, X. Li, M. Landis, J.M. Dixon, V.M. Neumeister, A. Sjolund, D.L. Rimm, H. Wong, A. Rodriguez, J.I. Herschkowitz, C. Fan, X. Zhang, X. He, A. Pavlick, M.C. Gutierrez, L. Renshaw, A.A. Larionov, D. Faratian, S.G. Hilsenbeck, C.M. Perou, M.T. Lewis, J.M. Rosen, and J.C. Chang Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features Proc. Natl. Acad. Sci. U.S.A. 106 2009 13820 13825
121. E. Lim, F. Vaillant, D. Wu, N.C. Forrest, B. Pal, A.H. Hart, M.L. Asselin-Labat, D.E. Gyorki, T. Ward, A. Partanen, F. Feleppa, L.I. Huschtscha, H.J. Thorne, S.B. Fox, M. Yan, J.D. French, M.A. Brown, G.K. Smyth, J.E. Visvader, and G.J. Lindeman Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Nat. Med. 15 2009 907 913
122. A. Prat, and C.M. Perou Deconstructing the molecular portraits of breast cancer Mol. Oncol. 5 2011 5 23
123. M. Yu, A. Bardia, B.S. Wittner, S.L. Stott, M.E. Smas, D.T. Ting, S.J. Isakoff, J.C. Ciciliano, M.N. Wells, A.M. Shah, K.F. Concannon, M.C. Donaldson, L.V. Sequist, E. Brachtel, D. Sgroi, J. Baselga, S. Ramaswamy, M. Toner, D.A. Haber, and S. Maheswaran Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition Science 339 2013 580 584
124. D. Sarrio, S.M. Rodriguez-Pinilla, D. Hardisson, A. Cano, G. Moreno-Bueno, and J. Palacios Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype Cancer Res. 68 2008 989 997
125. F.M. Davis, T.A. Stewart, E.W. Thompson, and G.R. Monteith Targeting EMT in cancer: opportunities for pharmacological intervention Trends Pharmacol. Sci. 35 2014 479 488
126. K. Kurose, K. Gilley, S. Matsumoto, P.H. Watson, X.P. Zhou, and C. Eng Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas Nat. Genet. 32 2002 355 357
127. F. Moinfar, Y.G. Man, L. Arnould, G.L. Bratthauer, M. Ratschek, and F.A. Tavassoli Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis Cancer Res. 60 2000 2562 2566
128. W. Qiu, M. Hu, A. Sridhar, K. Opeskin, S. Fox, M. Shipitsin, M. Trivett, E.R. Thompson, M. Ramakrishna, K.L. Gorringe, K. Polyak, I. Haviv, and I.G. Campbell No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas Nat. Genet. 40 2008 650 655
129. B. Aktas, M. Tewes, T. Fehm, S. Hauch, R. Kimmig, and S. Kasimir-Bauer Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Breast Cancer Res. 11 2009 R46
130. G. Kallergi, M.A. Papadaki, E. Politaki, D. Mavroudis, V. Georgoulias, and S. Agelaki Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients Breast Cancer Res. 13 2011 R59
131. C. Alix-Panabieres, and K. Pantel Challenges in circulating tumour cell research Nat. Rev. Cancer 14 2014 623 631
132. E. Ozkumur, A.M. Shah, J.C. Ciciliano, B.L. Emmink, D.T. Miyamoto, E. Brachtel, M. Yu, P.I. Chen, B. Morgan, J. Trautwein, A. Kimura, S. Sengupta, S.L. Stott, N.M. Karabacak, T.A. Barber, J.R. Walsh, K. Smith, P.S. Spuhler, J.P. Sullivan, R.J. Lee, D.T. Ting, X. Luo, A.T. Shaw, A. Bardia, L.V. Sequist, D.N. Louis, S. Maheswaran, R. Kapur, D.A. Haber, and M. Toner Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells Sci. Transl. Med. 5 2013 179ra147
133. M. Yu, A. Bardia, N. Aceto, F. Bersani, M.W. Madden, M.C. Donaldson, R. Desai, H. Zhu, V. Comaills, Z. Zheng, B.S. Wittner, P. Stojanov, E. Brachtel, D. Sgroi, R. Kapur, T. Shioda, D.T. Ting, S. Ramaswamy, G. Getz, A.J. Iafrate, C. Benes, M. Toner, S. Maheswaran, and D.A. Haber Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility Science 345 2014 216 220.